PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15517883-5 2004 Potential PPAR gamma agonists and antagonists inhibited the incorporation of thymidine into DNA of human prostate (PC3), colon (Caco-2) and breast (T47D) cancer cells but also affected NIH3T3 cells that have little or no expression of PPAR gamma. Thymidine 77-86 peroxisome proliferator activated receptor gamma Homo sapiens 10-20 14581151-7 2003 PPARgamma-overexpression or troglitazone treatment alone reduced the thymidine uptake by the HUVEC with or without TNFalpha treatment. Thymidine 69-78 peroxisome proliferator activated receptor gamma Homo sapiens 0-9 14581151-8 2003 There was a further decrease in the thymidine uptake with troglitazone treatment in the PPARgamma-overexpressed HUVEC. Thymidine 36-45 peroxisome proliferator activated receptor gamma Homo sapiens 88-97 10935488-5 1999 Treatment of the T24 bladder cancer cells with the TZD PPARgamma agonist troglitazone, dramatically inhibited 3H-thymidine incorporation and induced cell death. Thymidine 113-122 peroxisome proliferator activated receptor gamma Homo sapiens 55-64 11777901-4 2002 PPAR-gamma ligands 15-deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone reduced TXR mRNA expression levels as well as cell growth as assessed by [(3)H]thymidine incorporation. Thymidine 156-165 peroxisome proliferator activated receptor gamma Homo sapiens 0-10 16179407-8 2006 In this model, PAX8-PPARgamma expression was associated with enhanced growth as assessed by soft agar assays and thymidine uptake. Thymidine 113-122 peroxisome proliferator activated receptor gamma Homo sapiens 20-29